About the Dr. Susan Love Cancer Foundation
Susan M. Love, MD, MBA has dedicated her professional life to the eradication of breast cancer. What began as a career in the 1970’s quickly turned into a mission and as chief visionary officer of Dr. Susan Love Research Foundation (DSLRF), Dr. Love oversees an active research program centered on breast cancer cause and prevention.
Dr. Love has always been a pioneer and entrepreneur. Her reputation as an activist comes from her role as one of the “founding mothers” of the breast cancer advocacy movement in the early 1990’s, as one of the founders of the National Breast Cancer Coalition (NBCC). President Clinton appointed Dr. Love to the National Cancer Advisory Board, on which she served from 1998-2004.
The Dr. Susan Love Research Foundation devotes over 80% of their funding to conducting research that are innovative and groundbreaking, such as their recent discovery – a self-reading ultrasound device which is helping women and men around the world detect and prevent cancer earlier. Additionally, the Foundation is devoted to treatments with ongoing support. They have worked with partners outside of the world of medicine, such as Pasadena’s JPL to develop a mapping system to trace the potential development of cancer.
For more information on the Foundation, visit:
https://www.drsusanloveresearch.org/
About the John Wayne Cancer Research Foundation
Since 1981, the John Wayne name has been committed by the Wayne Family to cutting-edge cancer research and education, in memory of their father who died of stomach cancer in 1979. The Institute, previously known as the John Wayne Cancer Clinic at UCLA, was formed by the John Wayne Cancer Foundation and headed by eldest son Michael. Over the next decade, Michael Wayne served as Chairman of the Board - a position he held until his death in 2003. Patrick Wayne now serves as Chairman of the Board and provides continued determination toward the family's goal of curing this dreaded disease.
Today the Institute conducts multidisciplinary basic, clinical and translational research on many complex cancer problems, focusing in particular on melanoma, breast cancer, prostate cancer, colon cancer, neuroendocrine cancer, gastrointestinal cancer and sarcoma.
With renowned researchers and advanced technologies, JWCI has the unique ability to quickly and effectively react, explore, and investigate life-saving cancer treatments. Developed at the Institute, the Sentinel Node Biopsy is one such treatment. Now considered the worldwide standard of care for melanoma and breast cancer, the Sentinel Node Biopsy has revolutionized treatment options by offering a minimally invasive technique to determine the spread of tumor cells.
More information can be found at: https://johnwayne.org